ABEV vs. BUD, DEO, KDP, CCU, COCO, WEST, BRCC, WVVI, BLNE, and CASK
Should you be buying Ambev stock or one of its competitors? The main competitors of Ambev include Anheuser-Busch InBev SA/NV (BUD), Diageo (DEO), Keurig Dr Pepper (KDP), Compania Cervecerias Unidas (CCU), Vita Coco (COCO), Westrock Coffee (WEST), BRC (BRCC), Willamette Valley Vineyards (WVVI), Beeline (BLNE), and Heritage Distilling (CASK). These companies are all part of the "beer & liquor" industry.
Ambev vs. Its Competitors
Anheuser-Busch InBev SA/NV (NYSE:BUD) and Ambev (NYSE:ABEV) are both large-cap consumer staples companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, media sentiment, earnings, institutional ownership, profitability, valuation, dividends and risk.
Anheuser-Busch InBev SA/NV has a beta of 0.82, suggesting that its stock price is 18% less volatile than the S&P 500. Comparatively, Ambev has a beta of 0.74, suggesting that its stock price is 26% less volatile than the S&P 500.
Ambev has a net margin of 15.76% compared to Anheuser-Busch InBev SA/NV's net margin of 11.74%. Anheuser-Busch InBev SA/NV's return on equity of 16.09% beat Ambev's return on equity.
5.5% of Anheuser-Busch InBev SA/NV shares are held by institutional investors. Comparatively, 8.1% of Ambev shares are held by institutional investors. 4.5% of Anheuser-Busch InBev SA/NV shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
Anheuser-Busch InBev SA/NV pays an annual dividend of $0.85 per share and has a dividend yield of 1.3%. Ambev pays an annual dividend of $0.11 per share and has a dividend yield of 4.7%. Anheuser-Busch InBev SA/NV pays out 24.6% of its earnings in the form of a dividend. Ambev pays out 68.8% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.
Anheuser-Busch InBev SA/NV has higher revenue and earnings than Ambev. Ambev is trading at a lower price-to-earnings ratio than Anheuser-Busch InBev SA/NV, indicating that it is currently the more affordable of the two stocks.
In the previous week, Anheuser-Busch InBev SA/NV had 7 more articles in the media than Ambev. MarketBeat recorded 11 mentions for Anheuser-Busch InBev SA/NV and 4 mentions for Ambev. Anheuser-Busch InBev SA/NV's average media sentiment score of 0.98 beat Ambev's score of 0.53 indicating that Anheuser-Busch InBev SA/NV is being referred to more favorably in the media.
Anheuser-Busch InBev SA/NV currently has a consensus target price of $71.50, indicating a potential upside of 5.97%. Ambev has a consensus target price of $2.60, indicating a potential upside of 10.64%. Given Ambev's higher probable upside, analysts plainly believe Ambev is more favorable than Anheuser-Busch InBev SA/NV.
Summary
Anheuser-Busch InBev SA/NV beats Ambev on 13 of the 19 factors compared between the two stocks.
Get Ambev News Delivered to You Automatically
Sign up to receive the latest news and ratings for ABEV and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding ABEV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Related Companies and Tools
This page (NYSE:ABEV) was last updated on 7/11/2025 by MarketBeat.com Staff